Play Video
Play Video

Transforming
Colorectal Surgery

Transforming
Colorectal Surgery

Colospan offers a unique alternative to the diverting stoma by providing a temporary intraluminal bypass which helps reduce the contact of fecal materials with the anastomotic site. This temporary diversion solution is removed without surgery in under two weeks and aims to minimize post-operative complications for a comfortable recovery.

Introducing CG-100

CG-100 is a temporary intraluminal bypass device designed to reduce the rate of diverting stoma and their related complication. CG-100 divert fecal material from coming into contact with the anastomotic site during its critical healing period thereby reducing the life-threatening symptoms related to clinical anastomotic leaks.

Asset-15-1
RESTORING PATIENTS' QUALITY OF LIFE
icons_cologuard
REDUCING CLINICAL COMPLICATIONS
Asset-14-1
REDUCING COST OF CARE
Asset-18
TRANSFORMING COLORECTAL SURGERY

PROFESSIONALS

Ease your surgical procedures and improve clinical outcomes

PATIENTS

Go back to your normal life quickly with great clinical outcomes

HEALTHCARE PROVIDERS

Surgery free Removal, improve outcomes, reduced costs

The CG-100 clinical study is underway at select sites.

If you are a rectal cancer patient between the ages of
22-75 planned to undergo a colorectal surgery
and would like to be considered for the study, click here. 

What We Do

Colospan is a medical device company dedicated to addressing the first and foremost challenge in colorectal surgery – anastomotic leaks. We strive to optimize the outcomes of colorectal surgery by creating a unique alternative to the diverting stoma. Colospan enjoys solid financial backing from leading VCs in Israel, Europe and China and a Global strategic investor from the surgical space.

Colospan Ltd has received funding from the European Union’s EIC Accelerator program,

Project # 190124297 – CG-100 

Disclaimer: CG-100 received European CE mark in 2014 and is available in the European Union for commercial use, CG-100 is not approved for sale or distribution in the US and is limited by U.S. law to investigational use.  

Please read IFU before use and for additional info on indications, contraindications, warnings and precautions.

We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Privacy Policy. To agree to our use of cookies click Accept.